Search Results - "Maul, Julia"

Objective hand eczema severity assessment with automated lesion anatomical stratification by Amruthalingam, Ludovic, Mang, Nora, Gottfrois, Philippe, Gonzalez Jimenez, Alvaro, Maul, Julia‐Tatjana, Kunz, Michael, Pouly, Marc, Navarini, Alexander A.

“…Hand eczema (HE) is one of the most frequent dermatoses, known to be both relapsing and remitting. Regular and precise evaluation of the disease severity is…”
Get full text

The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study by Ring, Hans Christian, Yao, Yiqiu, Maul, Julia‐Tatjana, Ingram, John R., Frew, John W., Thorsen, Jonathan, Nielsen, Mia‐Louise, Wu, Jashin J., Thyssen, Jacob P., Thomsen, Simon F., Egeberg, Alexander

“…SUMMARY Background Prolonged systemic antibiotic treatment is often a part of management of hidradenitis suppurativa (HS). Although biologic therapies are now…”
Get full text

Primary Localized Cutaneous Amyloidosis: A Retrospective Study of an Uncommon Skin Disease in the Largest Tertiary Care Center in Switzerland by Guillet, Carole, Steinmann, Simona, Maul, Julia-Tatjana, Kolm, Isabel

“…Primary localized cutaneous amyloidosis (PLCA) is defined by the deposition of amyloid protein in the skin without systemic involvement. There are four…”
Get more information

Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications by Maul, Julia‐Tatjana, Guillet, Carole, Oschmann, Anna, Maul, Lara Valeska, Meier‐Schiesser, Barbara, Stadler, Pia‐Charlotte, French, Lars E., Kerl, Katrin

“…Cutaneous lichenoid drug eruptions (LDE) are adverse drug reactions (ADR) characterized by symmetric, erythematous, violaceous papules reminiscent but rarely…”
Get full text

Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort study by Thyssen, Jacob P., Nymand, Lea K., Maul, Julia‐Tatjana, Schmid‐Grendelmeier, Peter, Wu, Jashin J., Thomsen, Simon Francis, Egeberg, Alexander

“…Background Use of Janus kinase 1 inhibitors in moderate‐to‐severe atopic dermatitis (AD) is associated with incident acne in adolescent and adults that is…”
Get full text

Secukinumab treatment of hidradenitis suppurativa: questions remain by Maul, Julia-Tatjana, Kolios, Antonios G A, Thomsen, Simon Francis, Ring, Hans Christian

Get full text

Drug Survival of Biologics in Patients With Hidradenitis Suppurativa by Ring, Hans Christian, Maul, Julia-Tatjana, Yao, Yiqiu, Wu, Jashin J, Thyssen, Jacob P, Thomsen, Simon F, Egeberg, Alexander

“…Biologics are important in treating patients with hidradenitis suppurativa (HS). However, to our knowledge, data on their real-life performance and treatment…”
Get more information

Association between electronic-cigarette use and atopic dermatitis among United States adults by Smith, Brandon, Engel, Priya, Collier, Michael R., Devjani, Shivali, Javadi, Sogol Stephanie, Maul, Julia-Tatjana, Wu, Jashin J.

Get full text

Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT) by Verardi, Fabio, Maul, Lara Valeska, Borsky, Kim, Steinmann, Simona, Rosset, Nina, Pons, Hector Ortega, Sorbe, Christina, Yawalkar, Nikhil, Micheroli, Raphael, Egeberg, Alexander, Thyssen, Jacob P., Heidemeyer, Kristine, Boehncke, Wolf‐Henning, Conrad, Curdin, Cozzio, Antonio, Pinter, Andreas, Kündig, Thomas, Navarini, Alexander A., Maul, Julia‐Tatjana

“…Background Psoriasis is a disease that often requires prolonged systemic treatment. It is important to determine the safety of available therapies. There is…”
Get full text

Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study by Goessinger, Elisabeth Victoria, Niederfeilner, Johannes‐Christian, Cerminara, Sara, Maul, Julia‐Tatjana, Kostner, Lisa, Kunz, Michael, Huber, Stephanie, Koral, Emrah, Habermacher, Lea, Sabato, Gianna, Tadic, Andrea, Zimmermann, Carmina, Navarini, Alexander, Maul, Lara Valeska

“…Background Artificial intelligence (AI) shows promising potential to enhance human decision‐making as synergistic augmented intelligence (AuI), but requires…”
Get full text

Incidence of atopic conditions in people with psoriasis: a population-based analysis by Kirsten, Natalia, Mohr, Nicole, Maul, Julia-Tatjana, Augustin, Matthias

“…Background Large-scale data on the association between psoriasis and atopic diseases are scarce. Objectives To evaluate the concomitant prevalence of atopic…”
Get full text

Gender differences in psoriasis: a Swiss online psoriasis survey by Murer, Carla, Sgier, David, Mettler, Sofia Kyonhi, Guillet, Carole, Maul, Julia-Tatjana, Djamei, Vahid, Navarini, Alexander A., Anzengruber, Florian

“…Physicians’ and patients’ perspectives can vary significantly. For a long time, physicians considered psoriasis a non-pruritic dermatosis until a survey found…”
Get full text

S2k guideline diagnosis, prevention, and therapy of hand eczema by Bauer, Andrea, Brans, Richard, Brehler, Randolf, Büttner, Marion, Dickel, Heinrich, Elsner, Peter, Fartasch, Manigé, Herzog, Claudia, John, Swen‐Malte, Köllner, Arno, Maul, Julia‐Tatjana, Merk, Hans, Molin, Sonja, Nast, Alexander, Nikolakis, Georgios D., Schliemann, Sybille, Skudlik, Christoph, Weisshaar, Elke, Werfel, Thomas, Zidane, Miriam, Worm, Margitta

“…Summary The consensus‐based guideline “Diagnosis, prevention, and treatment of hand eczema (HE)” provides concrete instructions and recommendations for…”
Get full text

Impact of the pre-biologic treatment journey on biologic drug survival in psoriasis: A nationwide cohort study by Thein, David, Nielsen, Mia-Louise, Maul, Julia-Tatjana, Thomsen, Simon Francis, Thyssen, Jacob P, Egeberg, Alexander

“…It is unknown whether the pre-biologic treatment journey affects subsequent biologic drug survival. To examine the potential impact of a complex treatment…”
Get full text

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis by Valenzuela, Fernando, De La Cruz, Claudia, Lecaros, Cristóbal, Fernández, Javier, Hevia, Gonzalo, Maul, Lara Valeska, Thyssen, Jacob P., Vera‐Kellet, Cristián, Egeberg, Alexander, Armijo, Daniela, Pizarro, Cristian, Riveros, Tatiana, Correa, Hernán, Guglielmetti, Antonio, Didaskalu, Johannes A., Wu, Jashin J., Griffiths, Christopher E. M., Romiti, Ricardo, Maul, Julia‐Tatjana

“…Background Psoriasis is a chronic inflammatory skin disease associated with several important medical comorbidities. There are scant data available on the…”
Get full text

IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes by Satoh, Takashi K, Mellett, Mark, Meier-Schiesser, Barbara, Fenini, Gabriele, Otsuka, Atsushi, Beer, Hans-Dietmar, Rordorf, Tamara, Maul, Julia-Tatjana, Hafner, Jürg, Navarini, Alexander A, Contassot, Emmanuel, French, Lars E

“…Epidermal growth factor receptor (EGFR) and MEK inhibitors (EGFRi/MEKi) are beneficial for the treatment of solid cancers but are frequently associated with…”
Get full text

Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? by Cerminara, Sara E., Cheng, Phil, Kostner, Lisa, Huber, Stephanie, Kunz, Michael, Maul, Julia-Tatjana, Böhm, Jette S., Dettwiler, Chiara F., Geser, Anna, Jakopović, Cécile, Stoffel, Livia M., Peter, Jelissa K., Levesque, Mitchell, Navarini, Alexander A., Maul, Lara Valeska

“…Convolutional neural networks (CNNs) have outperformed dermatologists in classifying pigmented skin lesions under artificial conditions. We investigated, for…”
Get full text

Predictors of initiating biologics in the treatment of psoriasis by Linnemann, Emilia, Nielsen, Mia‐Louise, Maul, Lara Valeska, Richter, Clara, Dommann, Isabella, Zink, Alexander, Schlapbach, Christoph, Yawalkar, Nikhil, Conrad, Curdin, Cozzio, Antonio, Kündig, Thomas, Navarini, Alexander, Egeberg, Alexander, Maul, Julia‐Tatjana

“…Background Biologics are among the most effective therapies for psoriasis. However, many patients are only introduced to them at advanced stages of the disease…”
Get full text

Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study by Thein, David, Rosenø, Nana A.L., Maul, Julia-Tatjana, Wu, Jashin J., Skov, Lone, Bryld, Lars Erik, Rasmussen, Mads K., Ajgeiy, Kawa Khaled, Thomsen, Simon Francis, Thyssen, Jacob P., Egeberg, Alexander

“…The real-world efficacy of biologics may be insufficiently assessed through common drug survival studies. The objective was thus to examine the real-world…”
Get full text

Secukinumab for Acrodermatitis Continua of Hallopeau by Muggli, David, Maul, Julia-Tatjana, Anzengruber, Florian, Fopp, Myriam Wyss, Navarini, Alexander A

Get more information